Home » GUIDANT REVEALS RESULTS OF CLINICAL TRIAL ABSORB
GUIDANT REVEALS RESULTS OF CLINICAL TRIAL ABSORB
Guidant Corporation revealed results
of clinical trial designed to evaluate the safety of a fully bioabsorbable everolimus
eluting stent platform for the treatment of coronary artery disease.
Trading
Markets
KEYWORDS FDAnews Device Daily Bulletin
Upcoming Events
-
07May
-
14May
-
30May